Leadership transitions often bring a mix of uncertainty and opportunity. But at Acadia Healthcare Co., newly appointed CEO Chris Hunter is making it clear that the company’s core strategic direction remains firmly intact—with a sharp focus on mental health facility growth, addressing behavioral health disparities in underserved markets, and exploring digital tools to elevate service delivery and efficiency.
Only three weeks into the role, Hunter spoke during Acadia’s first-quarter earnings call and emphasized that his leadership would continue to build upon the momentum created by former CEO Debbie Osteen. With demand for behavioral health services at an all-time high across the U.S., Hunter’s mission is to scale operations and reach more communities while refining the systems and technologies that support care delivery.
“I want to build upon our strong momentum and extend our market reach to more patients and communities,” Hunter stated. “We will continue to execute on our strategic growth plans, as we address the unmet needs that exist across all service lines.”
Staying the Course While Looking Forward
Hunter’s message was clear: Acadia Healthcare is not undergoing a change in direction—it’s entering a phase of acceleration. The company’s existing blueprint focuses on four key levers of strategic growth:
- Expanding bed capacity and inpatient facility reach
- Opening more Comprehensive Treatment Centers (CTCs) for opioid use disorder
- Growing in underserved communities
- Exploring mergers and acquisitions (M&A) as a tool for scale
These pillars have helped establish Acadia as a leader in behavioral health, with more than 230 facilities across 40 states and Puerto Rico. Now, under Hunter’s leadership, that expansion is set to quicken. In total, the company plans to add 600 new beds by the end of 2022 through multiple methods—expanding capacity at current facilities, opening entirely new inpatient centers, launching two new joint-venture facilities, and establishing at least six new CTCs.
This level of development signals that Acadia is leaning into demand trends, especially surrounding substance use disorders like opioid addiction, where comprehensive, medication-assisted treatment is becoming a critical need across many regions. This focus on mental health facility growth not only addresses pressing community needs but also strengthens Acadia’s ability to provide integrated care.
“We’re positioned with real tailwinds from a demand standpoint across all four of our lines of business,” Hunter noted.
Financial Performance Backs Strategic Investment
Hunter’s optimism is grounded in tangible numbers. Acadia’s financial performance in Q1 2022 was robust, showing both top-line and bottom-line growth. Total revenue hit $616.7 million, marking an 11.9% increase from the same period in 2021. Adjusted EBITDA also saw a year-over-year rise—from $119.5 million in Q1 2021 to $135.5 million in Q1 2022.
These results reaffirm the company’s initial 2022 full-year revenue guidance of $2.55 billion to $2.6 billion, offering confidence to stakeholders and investors. For a company managing such a large portfolio of services—including inpatient psychiatric care, addiction treatment, and residential mental health programs—these results underscore that the organization is on solid footing even as it scales further.
The underlying patient volume also saw growth. Revenue per patient day rose 6.2%, and the number of patient days climbed 2.2%, signaling that more individuals are engaging with Acadia’s services, and at a higher rate of reimbursement. This sustained demand plays a crucial role in supporting ongoing mental health facility growth.
A Growing Role for Commercial Payers
One key contributor to this growth has been commercial payer rate increases, supported by Acadia’s long-standing partnerships and over 90% in-network penetration. CFO David Duckworth credited the company’s ability to maintain collaborative relationships at both local and corporate levels—especially during a period when inflation and cost of care delivery continue to rise.
“We have a team that maintains a close and collaborative relationship with our commercial and managed care payers,” Duckworth said. “We’re talking to them about the value that we bring, the programs that we design for their members, and the investments that we make.”
This focus on value-based care and outcome-driven dialogue is resonating with payers, making commercial relationships a consistent source of revenue growth. However, Duckworth acknowledged that Medicaid and Medicare rate increases tend to lag due to variability across states and slower regulatory cycles.
“Our view is that it may take longer across all of our Medicaid and certainly Medicare to receive appropriate rate increases,” he added. “We’ve seen a good environment for Medicaid in general, but the process can look different from one state to another.”
Building for the Future: Comprehensive Treatment and Underserved Market Penetration
Acadia Healthcare’s commitment to growing in underserved markets has long been a differentiator—and one that Hunter says remains a top priority. In many rural and low-income regions across the country, access to high-quality mental health and addiction treatment remains limited, especially for specialized care like inpatient psychiatric support or MAT (medication-assisted treatment) for opioid use disorder.
By expanding existing facilities and launching new treatment centers in partnership with health systems or local agencies, Acadia is uniquely positioned to meet those needs. This model also provides long-term benefits in terms of referral networks, community trust, and sustainable patient volume.
In particular, Acadia’s Comprehensive Treatment Centers (CTCs) offer integrated services for opioid addiction that include FDA-approved medications like methadone or buprenorphine, along with counseling and behavioral therapy. With at least six new CTCs planned for 2022, the company is making a strong statement that opioid treatment remains central to its mission and will be a significant driver of mental health facility growth.
M&A as a Strategic Growth Lever
Acadia has historically relied on both organic growth and mergers and acquisitions to expand its national footprint. Hunter emphasized that M&A remains on the table as a key strategy, especially when it helps the company enter new geographies, diversify services, or build scale more efficiently.
Hunter’s background in managed care and digital health equips him well to evaluate acquisition targets that align with future-focused, tech-enabled behavioral health delivery models. As competition for assets heats up in the behavioral health M&A space, Acadia’s infrastructure, payer relationships, and brand recognition offer a strong advantage. This strategic use of acquisitions will continue to fuel the company’s mental health facility growth trajectory.
Embracing Technology—With Caution
Another area where Hunter brings fresh perspective is digital innovation. While Acadia is deeply rooted in in-person care—especially inpatient psychiatric and residential services—Hunter acknowledged the growing importance of digital tools in the behavioral health sector.
“I would like to see the behavioral sector embrace technology and digitization,” he said. “Take advantage of cost benefits, efficiencies, and revenue enhancements—and other ways to just further and enhance our platform.”
Still, Hunter emphasized that digital care will not replace inpatient services. Rather, he sees an opportunity for thoughtful integration of technology—whether it’s telehealth for outpatient support, digital assessments, care coordination tools, or even strategic partnerships with tech firms.
Hunter’s background includes leadership at TriZetto, a healthcare IT firm, and he currently serves on the board of AfterNext HealthTech. That digital fluency could help Acadia selectively incorporate tools that drive better clinical outcomes, improve patient engagement, or streamline administrative operations—all of which will complement ongoing mental health facility growth by creating a stronger, more efficient care delivery system.
“While we don’t think it will ultimately be a replacement for our inpatient care,” Hunter said, “there will be an opportunity for us to continue to look at innovation and to potentially even think through whether it makes sense to partner in certain instances as well.”
The Road Ahead for Acadia Healthcare
Chris Hunter’s arrival as CEO comes at a pivotal time in the behavioral health industry. The mental health crisis in the United States has only deepened in the wake of the COVID-19 pandemic, with surging rates of depression, anxiety, substance use, and suicide. Behavioral health operators with national scale and established payer relationships—like Acadia—are uniquely positioned to help meet that rising demand.
But scale alone isn’t enough. As Hunter made clear, the company’s future success hinges on its ability to grow strategically—building where it matters most, partnering when it makes sense, and investing in technology that enhances care rather than distracting from it.
From a revenue standpoint, Acadia is entering 2022 from a position of strength. From a strategic standpoint, the path is clear: continue the expansion of inpatient and outpatient services, invest in high-demand service lines like opioid use treatment, maintain collaborative payer relationships, and explore innovation with a steady hand.
For Acadia Healthcare, the story under Hunter’s leadership will likely be one of continued momentum—with a sharper lens on modernizing and scaling access for communities that need it most through deliberate mental health facility growth.
